ProBio CDMO

GenScript ProBio is a global Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for biologics and gene and cell therapies. As a subsidiary of GenScript Biotech Corporation, the company offers a comprehensive portfolio including antibody drug discovery, process development, and clinical to commercial-scale GMP manufacturing. Their technical expertise encompasses monoclonal antibodies, bispecifics, recombinant proteins, plasmid DNA, viral vectors, and mRNA. With state-of-the-art facilities in China and the United States, GenScript ProBio supports biopharmaceutical partners in accelerating the transition of innovative drug candidates from the laboratory to the clinic. The company is recognized for its proprietary technology platforms and commitment to high-quality standards in the rapidly evolving life sciences sector.